CS
EPIX

Candriam SCA’s ESSA Pharma EPIX Stock Holding History

Candriam SCA’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-417,532
Closed -$760K – 871
2022
Q3 		$760K Sell
417,532
-149,811
-26% -$395K 0.01% 769
2022
Q2 		$1.79M Sell
567,343
-20,725
-4% -$116K 0.01% 527
2022
Q1 		$3.63M Sell
588,068
-38,208
-6% -$336K 0.02% 411
2021
Q4 		$8.89M Buy
626,276
+325,751
+108% +$3.63M 0.06% 278
2021
Q3 		$2.4M Hold
300,525
– – 0.02% 547
2021
Q2 		$8.59M Buy
300,525
+300,508
+1,767,694% +$8.74M 0.06% 309
2021
Q1 		$0 Buy
+17
New +$395 ﹤0.01% 810

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Candriam SCA's EPIX Position: Q4 2022 in Review

Candriam SCA sold out of ESSA Pharma (EPIX) in Q4 2022, closing a stake of 417,532 shares — an estimated $760K sold.

Candriam SCA first reported a position in EPIX in Q1 2021 and held it in 7 quarters. The position peaked at $8.89M in Q4 2021. 45 funds tracked by Wall St. Rank hold EPIX as of Q4 2022.

  • Candriam SCA reported no remaining ESSA Pharma position as of Q4 2022 after selling out during the quarter.
  • Candriam SCA sold 417,532 ESSA Pharma shares in Q4 2022, an estimated $760K.
  • Candriam SCA first reported a position in ESSA Pharma in Q1 2021 and held it in 7 quarters.
  • Candriam SCA's ESSA Pharma position peaked at $8.89M in Q4 2021.
  • 45 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2022.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.